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Sixty cases of febrile seizures from a Chinese cohort had previously been reported with a strong association between variants in
the seizure-related (SEZ) 6 gene and febrile seizures. They found a striking lack of genetic variation in their controls. We found
geneticvariationin SEZ6 atsimilarlevelsatthesameDNAsequencepositionsinour94febrileseizurecasesasinour96unaﬀected
controls. Two of our febrile seizure cases carried rare variants predicted to have damaging consequences. Combined with some of
the variants from the Chinese cohort, these data are compatible with a role for SEZ6 as a susceptibility gene for febrile seizures.
However, the polygenic determinants underlying most cases of febrile seizures with complex inheritance remain to be determined.
1.Introduction
Febrile seizures aﬀect 3% of infants between the ages of three
months and ﬁve years of age and are associated with fever in
the absence of intracranial infection or other deﬁned cause.
Febrile seizures are generally thought to be multifactorial
with the genetic component polygenic, as suggested by di-
minishing risks beyond ﬁrst degree relatives. As with other
genetic forms of epilepsy, there are rare families with pre-
sumedautosomaldominantinheritanceoffebrileseizures[1,
2]. These may lead to gene identiﬁcation potentially offering
leads to genes and gene families that may harbour suscep-
tibility variants for the vast majority of febrile seizures with
complex inheritance.
Seizure-related (SEZ) 6 is a protein of 994 amino acids
which is thought to play a role in neuronal cell to cell signal-
ling. Normal functioning maintains a balance between den-
drite growth and branching to optimize dendritic trees for
synaptic connectivity [3]. SEZ6 was originally cloned follow-
ing upregulation in mouse neurons after seizure induction
using pentylenetetrazole (PTZ) stimulation [4]. This raises
the question: can disturbances in the amount of transcribed
SEZ6 through naturally occurring mutations predispose to
seizures? Yu et al. [5] subsequently reported a strong associ-
ation between SEZ6 and human febrile seizures indicating
that SEZ6 is a susceptibility gene for febrile seizures with
complex inheritance.
2. Methods
Ninety-four (47 males, 47 females) unrelated cases of simple
febrile seizure were screened for SEZ6 mutations in genomic
DNAisolatedfromvenousblood.Diagnosiswasbasedonthe
observation of a seizure which ceased within approximately
three minutes and which did not recur within a 24-hour
period. For all cases, seizure onset occurred after three2 Neurology Research International
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Figure 1: Evolutionary conservation of amino acid positions across vertebrates at sites of rare and common nonsynonymous amino acid
substitutions within the SEZ6 protein.
months of age and had ceased in all subjects within ﬁve years
of age. Ninety-six anonymous blood donors from the same
Caucasian population were used as controls. None of the
aﬀected children required lumbar puncture, electroencepha-
lograhy, blood studies, or neuroimaging, consistent with the
management recommendations of Duﬀner et al. [6].
The 17 SEZ6 exons were PCR ampliﬁed using the ﬂank-
ing intronic primers listed in Table 1.P r i m e r sw e r ed e s i g n e d
based on the sequence of SEZ6 transcript variant 1 (NCBI
Accession Number NM 178860). Samples were screened
by single-stranded conformation polymorphism analysis
(SSCA) using the GelScan 3000 (Corbett Research) accord-
ing to the manufacturer’s instructions. The functional ef-
fects of nonsynonymous variants were predicted using the
PolyPhen-2 tool (http://genetics.bwh.harvard.edu/pph2/).
3. Results
Nine sequence variants were detected within the protein-
codingregionsoftheSEZ6 gene(Table2).Fiveofthechanges
were synonymous and did not change the amino acid, but
four of the changes were nonsynonymous and altered the
amino acid. Two of the missense changes, in exon 2 (c.142
C>A; p.P48T) and exon 7 (c.1568 G>A; p.R523H), are both
low-frequency changes but are present in cases of febrile
seizures and in controls. They each aﬀect amino acids which
are highly conserved across vertebrate species (Figure 1).
Both of these changes were predicted by PolyPhen-2 to be
damaging, with scores of 0.955 and 1.000, respectively. Nei-
ther change has been reported as a known variant in dbSNP
(http://www.ncbi.nlm.nih.gov/snp/).
The remaining two missense changes, the exon 8 c.1636
A>G (causing p.T546A) and exon 12 c.2417 T>C (causing
p.M806T), were common, occurring with approximately
equal frequency in both febrile seizure cases and con-
trols. They are moderately conserved across vertebrates.
Both of these changes are listed in dbSNP (rs1976165
and rs12941884, resp.) with frequencies in the European
population similar to those seen in our patient and control
groups. These two changes were predicted to be benign byNeurology Research International 3
PolyPhen-2 analysis. Allele frequencies aﬀecting all coding
regions did not markedly diﬀer between febrile seizures
(N = 94) and controls (N = 96). There was no evidence
in our population, from the sample size examined, for an
associationofthestrengthpreviouslyreportedbetweenSEZ6
genetic variation and febrile seizures. We also detected an
insertion in intron 5 of the SEZ6 gene (IVS5+10-11insC)
with allele frequencies of 51.6% in patients and 57.3% in
controls. This change is intronic and likely benign.
4. Discussion
The most common of the SEZ6 variants in the population
studied is the IVS5+10-11insC. This is the same variant
reported by Yu et al. [5] as occurring in exon 5 at their
position1435inthecDNA(theirGenBankaccessionnumber
GI:20143984). The discrepancy between the position they
report for this polymorphism and the position we report
arises from diﬀerences in the cDNA sequences used. In both
isoforms of SEZ6 currently listed in GenBank (NM 178860
and NM 001098635), the variant is intronic. It is likely that
this variant is a benign polymorphism, as evidenced by its
high frequency among both cases and controls in our study
(Table 2). The variant is also listed in dbSNP (rs58747412),
but the entry does not include population frequency data.
Critical examination of the data reported by Yu et al.
[5] reveals that in addition to the intronic variant described
above, a threonine to alanine missense variant T546A, ob-
served in four of their patients is in fact the SNP rs1976165,
which we observed at similar frequency in both patients and
controls.
Contrary to the report of Yu et al. we detected the same
degree of genetic variation in both the febrile seizure cases
and our 96 controls. Their control numbers were not of
adequatesize,andintheirfebrileseizurecases,theymisinter-
preted the presence of naturally occurring genetic variations
to be multiple pathogenic mutations present only among the
febrile seizure patients.
Data from dbSNP shows that SEZ6 is a highly variable
gene, with 17 nonsynonymous coding SNPs listed. Findings
ofvariantsinthisgene,therefore,needtobeinterpretedwith
caution in the absence of additional data (such as protein
alignments, in silico pathogenicity predictions, or functional
studies) indicating that the variants are indeed deleterious.
PolyPhen-2 predictions indicate that only three or perhaps
four of the eight coding variants reported by Yu et al. are
likely to be deleterious. These and our data reporting two
additional potentially damaging rare variants are suggestive
of a contribution of SEZ6 to a genetic predisposition to FS in
ap r o p o r t i o no fc a s e s .
The extent of the evolutionary conservation for some
of the variants detected warrants further investigation using
much larger sample sizes. Massively parallel sequencing
(MPS) [7] now delivers the sensitivity to detect all rare vari-
ants. The focus needs to shift to rare variants [8] and statis-
tical developments enabling association tests on rare variants
[9]. The polygenic heterogeneity model [10, 11] is likely ap-
plicable to febrile seizures as well as for genetic generalised
Table 1: Primers used to amplify SEZ6 exons for mutation screen-
ing.
SEZ6-1F CGT GGT GCT GAT TCT GTC AG
SEZ6-1R TTG GAC TGG GCA GCC AGA TG
SEZ6-2.1F TGT AGT TCC GTG ATT CTC AGC
SEZ6-2.1R TGG CCT CAG CTC CTC ATC TC
SEZ6-2.2F TTG AAG CTG CTC AAC CAC CAC
SEZ6-2.2R ATG TCT CCA GGA CCC TCT TG
SEZ6-2.3F CTA TGC TTC GAA TCA CAG CTC
SEZ6-2.3R TGG CAC AGT GTC AGA GAC AG
SEZ6-3F TTA GTT GGA CCA CTT CAC CAG
SEZ6-3R ACA TCC TCT CAT AGC ATG TG
SEZ6-4F GCA GCA GGA AGA AGT CTG AC
SEZ6-4R TGC TCC TTC CCT CTA GGA TG
SEZ6-5F CTG CAC ACA TAC ACA GTG TC
SEZ6-5R AAA GTG GCA GAG AGC AAC AG
SEZ6-6F ATA GGG AGG AAG GCA TGT TAG
SEZ6-6R TCC CTC CAG CAG GGT ATT AC
SEZ6-7F TAA TAC CCT GCT GGA GGG AC
SEZ6-7R GTG TGG GAG AAA GAC CCT AG
SEZ6-8F GCC CAC TGT GTT TAATAC CAG
SEZ6-8R TAT TCT CCT GGT ATG ACC CTG
SEZ6-9F AGC AAC ACC ATG GTA AGC TTG
SEZ6-9R TGG GCT GGA CAA GGG ATA TC
SEZ6-10F TAT CCC TTG TCC AGC CCA TC
SEZ6-10R TTG CCA TGG CTT GCT GTC TG
SEZ6-11F GGA CAG TCA CTT TGG TGC TG
SEZ6-11R TCC AGG AGA GAG GTT TGG AG
SEZ6-12F ATT GGC CTC TGC TTA GTT CTC
SEZ6-12R AGT GCA GTG AGG GTG TCA TG
SEZ6-13F GGA GGG AAA ACC TCT AGC TG
SEZ6-13R CAT TGG ACA TCT TTG CCA GAG
SEZ6- 1 4 F C T CC C TG C CT T AG T GG T TT G
SEZ6-14R CTC TCT CTT TCT CTG CCC TC
SEZ6-15F GGC AGA GGT GAG AGA ATA TG
SEZ6-15R TGA GGT ATG CAG GTA TGC AG
SEZ6-16F TGC ATA CCT GCA TAC CTC AC
SEZ6-16R AGC AAA GAA CTG GGT CTT GG
SEZ6-17F GGA AGG TGA ATT ATG GCC TG
SEZ6-17R GTT CTT CCC ACA GGT AGA TG
epilepsy. It predicts that rare variants conferring genetic sus-
ceptibility will be present in both cases and controls; how-
ever, their presence throughout the gene will be signiﬁcantly
higher in cases than in controls if large and adequately pow-
ered sample sizes are analysed for the true susceptibility
genes.
5. Conclusion
Taken together, portions of the data from the present study
and from Yu et al. [5]s u g g e s tar o l ef o rSEZ6 as a suscepti-
bility gene for febrile seizures. There is no reason to restrict4 Neurology Research International
Table 2: Genetic variation detected within SEZ6.
Amplicon/exon Position Amino acid
change
Febrile seizure
frequency (%)
N = 94
Control
frequency (%)
N = 96
Rare nonsynonymous missense substitutions
2.1 c.142 C>A P48T 0.5 0.5
7 c.1568 G>A R523H 1.1 0.5
Common nonsynonymous missense substitutions
8 c.1636 A>G ∗T546A 22.4 17.6
12 c.2417 T>C ∗∗M806T 10.6 15.6
Rare synonymous missense substitutions (benign)
2.1 c.213 G>A P71P 0.5 0.0
2.2 c.384 G>A A128A 0.5 0.0
5 c.1209 C>T P403P 0.5 0.5
7 c.1557 C>T G519G 0.5 0.5
Common synonymous missense substitutions (benign)
8 c.1737 C>T D579D 21.3 17.0
Common intronic insertion
5 IVS5+10-11insC 51.6 57.3
∗rs1976165; ∗∗rs12941884.
Numbering of variants in this table is based on the mRNA sequence for SEZ6 transcript variant 1 (NM 178860), with the A of the initiation codon numbered
as nucleotide 1.
SEZ6 a n a l y s e st of e b r i l es e i z u r e ss i n c et h i sg e n er e p r e s e n t sa
plausible candidate for any seizure disorder based on how it
was originally cloned [4]. A signiﬁcant proportion of febrile
seizure cases progress to afebrile seizures [12] suggesting
shared genetic determinants between febrile and a febrile
seizures. SEZ6 warrants further investigation as a suscepti-
bility gene for both febrile seizures and the epilepsies which
show complex inheritance.
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